CD20 is a CD marker—a molecule on the cell surface that can be used to identify and type a particular cell in the body. CD20 is found on the surface of B cells (a type of immune system cell). But ...

What Is B-Cell Lymphoma? B-cell lymphoma is a cancer that forms in your white blood cells called lymphocytes. These cells are made by your lymphatic system, which plays an important role in immunity.

An ultrasound scan is a procedure that uses high frequency sound waves to create a picture of a part of the inside of your body. The ultrasound scanner has a probe that gives off sound waves. The ...

Abstract: The difficulty in identifying lymph node malignancies, including lymphoma and metastatic tumors, pose a diagnostic challenge at their primary sites. Given the heterogeneity of lymph node ...

Ethical committee approval was not required for this research, as the study utilised anonymised NHS data collected as part of standard clinical care. Aims: Ultrasound (US) guided percutaneous splenic ...

A bone marrow transplant, or stem cell transplant, places blood stem cells back into the body. The transplant replaces cells that cancer or treatments have destroyed. People may have a bone marrow ...

About 30 percent of all non-Hodgkin lymphoma diagnoses in the United States are DLBCL. Although it is an aggressive cancer that can spread quickly, it is treatable. These can be symptoms of many ...

Painful armpit lumps are often due to a swollen axillary lymph node under the armpit. This is usually a sign that the body is fighting an infection, but it can sometimes indicate cancer.

Your 12-week ultrasound is meant to assess your baby's development at the end of the first trimester of your pregnancy. At week 12, the fetus's organs and body systems are formed, and you may actually ...

Background: The differential diagnosis of lymphadenopathy is an important determinant of prognosis in patients with breast cancer (BC). Invasive, fine needle aspiration (FNA) biopsy has been long ...

The following is a summary of “Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma,” published in the February 2025 issue of ...